Skip to main content

Ridgeback Capital Investments L.P.

13F filer · CIK 0001423994
Reported Aug 14, 2026
13F portfolio value$80.9MU.S. long equity reported on 13F
Positions1Not reported new · Not reported closed
Net flow last quarterNot reportedBuys minus sells
Top 10 positions weight100.0%Concentration

Holdings

13F · last 4 quarters free
Scroll for earlier quarters
CompanyValue% of portfolio% of companyPOSITION CHANGE qoq %First reported
Q2 2026Reported Aug 14, 20261 positions
REPLReplimune Group, Inc.$80.9M100.00%8.71%NewQ2 2026
Q4 2024Reported Feb 14, 20251 positions
PYXSPyxis Oncology, Inc.$560K100.00%0.60%NewQ4 2024
Q4 2023Reported Feb 14, 20241 positions
BCYCBicycle Therapeutics PLC$15.3M62.17%1.99%Not reportedQ4 2021
Q4 2022Reported Feb 14, 20232 positions
BCYCBicycle Therapeutics PLC$67M80.44%7.58%Not reportedQ4 2021
FSTXF-Star Therapeutics, Inc.$332K0.40%Not reportedNot reportedQ4 2021
Premium opens every quarter this fund has filed
SpoorBase

Not investment advice. We make every effort to keep the information on SpoorBase accurate, but errors may occur. SpoorBase does not guarantee the accuracy or completeness of any data, and any use of the information is at the user’s sole responsibility. Valuation multiples are calculated by SpoorBase and may contain errors. See Disclosures. © 2026 SpoorBase. All rights reserved.